Biggest changeAs a result of the unobservable inputs that were used to determine the expected volatility of the March 2023 Cargill Warrant, the fair value measurement of these warrants reflected a Level 3 measurement within the fair value measurement hierarchy. 49 Results of Operations Year Ended December 31, 2023 compared to Year Ended December 31, 2022 The following table sets forth our historical operating results for the periods indicated: Year Ended December 31, 2023 2022 $ Change % Change (in thousands) Sales $ 27,557 $ 19,474 8,083 42% Cost of goods sold (1)(2)(3) 25,341 17,259 8,082 47% Gross profit 2,216 2,215 1 —% Operating expenses: Research and development (2)(3) 16,086 14,059 2,027 14% Selling, general and administrative (2)(3) 64,559 82,682 (18,123) (22)% Goodwill impairment 38,481 — 38,481 100% Total operating expenses 119,126 96,741 22,385 23% Loss from operations (116,910) (94,526) (22,384) 24% Other income (expense): Change in fair value of warrant liability 18,483 — 18,483 100% Interest expense, net (25,745) (16,734) (9,011) 54% Other income 157 189 (32) (17)% Net loss $ (124,015) $ (111,071) (12,944) 12% (1) Amounts include the impact for non-cash increase in cost of goods sold attributable to the fair value basis adjustment to inventory in connection with the Pete's Acquisition as follows: Year Ended December 31, 2023 2022 $ Change % Change (in thousands) Cost of goods sold $ — $ 1,042 (1,042) (100)% Total business combination fair value basis adjustment to inventory $ — $ 1,042 (1,042) (100)% (2) Amounts include stock-based compensation as follows: Year Ended December 31, 2023 2022 $ Change % Change (in thousands) Cost of goods sold $ 123 $ 104 19 18% Research and development 1,464 2,057 (593) (29)% Selling, general and administrative 14,687 37,005 (22,318) (60)% Total stock-based compensation expense, net of amounts capitalized $ 16,274 $ 39,166 (22,892) (58)% (3) Amounts include depreciation and amortization as follows: Year Ended December 31, 2023 2022 $ Change % Change (in thousands) Cost of goods sold $ 3,513 $ 2,957 556 19% Research and development 2,505 1,304 1,201 92% Selling, general and administrative 7,114 6,166 948 15% Total depreciation and amortization $ 13,132 $ 10,427 2,705 26% 50 The following sections discuss and analyze the changes in the significant line items in our Consolidated Statements of Operations for the comparative periods in the table above.
Biggest changeNo goodwill remained on the Consolidated Balance Sheets as of December 31, 2024 and 2023. 49 Results of Operations Year Ended December 31, 2024 compared to Year Ended December 31, 2023 The following table sets forth our historical operating results for the periods indicated: Year Ended December 31, 2024 2023 $ Change % Change (in thousands) Sales $ 38,138 $ 27,557 10,581 38% Cost of goods sold (1)(2) 34,048 25,341 8,707 34% Gross profit 4,090 2,216 1,874 85% Operating expenses: Research and development (1)(2) 22,287 16,086 6,201 39% Selling, general and administrative (1)(2) 40,771 64,559 (23,788) (37)% Goodwill impairment — 38,481 (38,481) 100% Total operating expenses 63,058 119,126 (56,068) (47)% Loss from operations (58,968) (116,910) 57,942 (50)% Other income (expense): Change in fair value of warrant liability 811 18,483 (17,672) 100% Interest expense, net (58,923) (25,745) (33,178) 129% Other (expense) income, net (2,822) 157 (2,979) (1897)% Net loss $ (119,902) $ (124,015) 4,113 (3)% (1) Amounts include stock-based compensation as follows: Year Ended December 31, 2024 2023 $ Change % Change (in thousands) Cost of goods sold $ 73 $ 123 (50) (41)% Research and development 274 1,464 (1,190) (81)% Selling, general and administrative 3,001 14,687 (11,686) (80)% Total stock-based compensation expense, net of amounts capitalized $ 3,348 $ 16,274 (12,926) (79)% (2) Amounts include depreciation and amortization as follows: Year Ended December 31, 2024 2023 $ Change % Change (in thousands) Cost of goods sold $ 6,137 $ 3,513 2,624 75% Research and development 7,631 2,505 5,126 205% Selling, general and administrative 5,103 7,114 (2,011) (28)% Total depreciation and amortization $ 18,871 $ 13,132 5,739 44% The following sections discuss and analyze the changes in the significant line items in our Consolidated Statements of Operations for the comparative periods in the table above.
Net Cash Used In Investing Activities Net cash used in investing activities was $162.3 million for the year ended December 31, 2023, due primarily to purchases of equipment and other items for the Washington, Georgia, and Texas facilities.
Net cash used in investing activities was $162.3 million for the year ended December 31, 2023, due primarily to purchases of equipment and other items for the Washington, Georgia, and Texas facilities.
Net Cash Provided By Financing Activities Net cash provided by financing activities was $187.4 million for the year ended December 31, 2023, comprised of $152.6 million of proceeds from the issuance of debt and $35.0 million of proceeds from the sale and leaseback transaction for the California Facilities.
Net cash provided by financing activities was $187.4 million for the year ended December 31, 2023, comprised of $152.6 million of proceeds from the issuance of debt and $35.0 million of proceeds from the sale and leaseback transaction for the California Facilities.
Controlling the environmental conditions in both the 'Stack' and 'Flow' components of our growing system helps to ensure healthy, nutritious, consistent, and delicious products that are non-genetically modified organisms ("non-GMO"). We use 90% less water, 90% less land, and significantly less pesticides and herbicides than traditional outdoor agriculture operations.
Controlling the environmental conditions in both the 'Stack' and 'Flow' components of our growing system helps to ensure healthy, nutritious, and consistent products that are non-genetically modified organisms ("non-GMO"). We use 90% less water, 90% less land, and significantly less pesticides and herbicides than traditional outdoor agriculture operations.
As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. 54 Recent Accounting Pronouncements For more information about recent accounting pronouncements, see Note 2, in our Notes to Consolidated Financial Statements included in "Part II, Item 8.
As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. Recent Accounting Pronouncements For more information about recent accounting pronouncements, see Note 2 in our Notes to Consolidated Financial Statements included in "Part II, Item 8.
Today, our primary products include living butter lettuce – for which we are a leading provider with an approximate 80% share of the CEA market within the Western U.S. – as well as packaged leafy greens and cress.
Our primary products include living butter lettuce – for which we are a leading provider with an approximate 80% share of the CEA market within the Western U.S. – as well as packaged leafy greens and cress.
Certain of our accounting estimates are particularly important to our financial position and results of operations and require us to make difficult and subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Our management uses its judgment to determine the appropriate assumptions to be used in the determination of certain estimates.
Certain of our accounting estimates are particularly important to our financial position and results of operations and require us to make complex and subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Our management uses its judgment to determine the appropriate assumptions to be used in the determination of certain estimates.
Our proprietary process is a hybrid, utilizing vertical farming in early plant growth, followed by greenhouse farming for final grow out. We designed our Stack & Flow Technology ® to give our products exactly what they need at every step of their growth cycle.
Our proprietary process is a hybrid growing approach, utilizing vertical farming in early plant growth, followed by greenhouse farming for final grow out. We designed our Stack & Flow Technology ® to give our products exactly what they need at every step of their growth cycle.
In connection with the Sixth Amendment, we issued Cargill Financial 5.4 million warrants with a per share exercise price of $13.00 per share (both number of warrants and per share exercise price adjusted for the June 15, 2023 Reverse Stock Split (as defined in Note 12, Stockholders' Equity , to our Consolidated Financial Statements)) and a 5-year term that expires on March 28, 2028 (the "March 2023 Cargill Warrant").
In connection with the Sixth Amendment, we issued Cargill Financial 5.4 million warrants with a per share exercise price of $13.00 per share (both number of warrants and per share exercise price adjusted for the June 15, 2023 Reverse Stock Split (as defined in Note 11, Stockholders' Equity (Deficit) , to our Consolidated Financial Statements)) and a 5-year term that expires on March 28, 2028 (the "March 2023 Cargill Warrant").
We utilize a Black-Scholes option pricing model ("Black-Scholes model") to estimate the fair value of the March 2023 Cargill Warrant at each reporting date. The application of the Black-Scholes model utilizes significant assumptions, and estimates in determining an appropriate risk-free interest rate, volatility, term, dividend yield, discount due to exercise restrictions, and the fair value of common stock.
We utilize a Black-Scholes option pricing model ("Black-Scholes model") to estimate the fair value of the March 2023 Cargill Warrant at each reporting date. The application of the Black-Scholes model utilizes significant assumptions and estimates to determine an appropriate risk-free interest rate, volatility, term, dividend yield, discount due to exercise restrictions, and the fair value of common stock.
As a result, the March 2023 Cargill Warrant is accounted for at fair value until settled through exercise or expiration and is classified as a derivative warrant liability in the Consolidated Balance Sheet at December 31, 2023 in accordance with ASC Topic 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity .
As a result, the March 2023 Cargill Warrant is accounted for at fair value until settled through exercise or expiration and is classified as a derivative warrant liability in the Consolidated Balance Sheets at December 31, 2024 and 2023, in accordance with ASC Topic 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity .
Financing Obligations We have two financing obligations related to failed sale leaseback transactions for the California Facilities and the Montana Facility (see Note 9, Financing Obligations , to the Consolidated Financial Statements for additional detail on these transactions).
Financing Obligations We have two financing obligations related to failed sale leaseback transactions for the California Facilities and the Montana Facility (see Note 8, Financing Obligations , to the Consolidated Financial Statements for additional detail on these transactions).
Selling, General, and Administrative Expenses Selling, general, and administrative expenses consist of employee compensation, including salaries, benefits, and stock-based compensation for our executive, legal, finance, information technology, human resources and sales and marketing teams, expenses for third-party professional services, Pete's Acquisition related integration costs, insurance, marketing, advertising, computer hardware and software, and amortization of intangible assets, among others.
Selling, General, and Administrative Expenses Selling, general, and administrative expenses consist of employee compensation, including salaries, benefits, and stock-based compensation for our executive, legal, finance, information technology, human resources and sales and marketing teams, expenses for third-party professional services, insurance, marketing, advertising, computer hardware and software, and amortization of intangible assets, among others.
Subsequent to the amendments described in Note 8, Debt , of the Consolidated Financial Statements, Cargill Financial may in its discretion provide advances under the Facilities of up to $280.0 million (plus interest and fees paid in kind), including capital to fund construction at the Company’s facilities in Georgia, Texas, and Washington, subject to certain conditions.
Subsequent to the amendments described in Note 7, Debt , of the Consolidated Financial Statements, Cargill Financial may, at its discretion, provide advances under the Facilities of up to $393.7 million (plus interest and fees paid in kind), including capital to fund construction at the Company’s facilities in Georgia, Texas, and Washington, subject to certain conditions.
Company Overview Local Bounti is a controlled environment agriculture ("CEA") company that produces sustainably grown produce, focused today on living and loose leaf lettuce. Founded in 2018, and headquartered in Hamilton, Montana, Local Bounti utilizes its patented Stack & Flow Technology ® to grow healthy food sustainably and affordably.
Company Overview Local Bounti is a controlled environment agriculture ("CEA") company that produces sustainably grown produce, focused primarily on living and loose leaf lettuce, arugula, spinach, and basil. Founded in 2018 and headquartered in Hamilton, Montana, Local Bounti utilizes its patented Stack & Flow Technology ® to grow healthy food sustainably and affordably.
After performing the quantitative impairment test in accordance with ASC 350-20-35-3C, we determined that the carrying amount of our single reporting unit exceeded the fair value of the reporting unit, resulting in a goodwill impairment of $38.5 million for the year ended December 31, 2023. We did not record any impairment expense for the year ended December 31, 2022.
After performing the quantitative impairment test in accordance with ASC 350-20-35-3C, we determined that the carrying amount of our single reporting unit exceeded the fair value of the reporting unit, resulting in a goodwill impairment of $38.5 million for the year ended December 31, 2023.
The amendment amended the exercise price of the March 2023 Cargill Warrant from $13.00 to $6.50 per share of common stock (refer to Note 18, Subsequent Events , of the Consolidated Financial Statements for more information about the amendment to the March 2023 Cargill Warrant).
The amendment amended the exercise price of the March 2023 Cargill Warrant from $13.00 to $6.50 per share of common stock (refer to Note 7, Debt , of the Consolidated Financial Statements for more information about the amendment to the March 2023 Cargill Warrant).
Currently, our primary sources of liquidity and capital resources are cash on hand, cash flows generated from the sale of our products, and the Facilities (as defined below) with Cargill Financial.
Currently, our primary sources of liquidity and capital resources are cash on hand, cash flows generated from the sale of our products, and the credit facilities with Cargill Financial.
We also believe that local is the best kind of business, and we are committed to helping communities thrive for generations to come. We are committed to building empowered local teams. Together, we believe we are capable of extraordinary things.
We also believe that local is the best kind of business, and we are committed to helping communities thrive for generations to come. We are committed to building empowered local teams. Together, we believe we are capable of extraordinary achievements in sustainable agriculture.
We capitalize interest costs on borrowings during the construction period of major construction projects as part of the cost of the constructed assets. Interest expense, net increased by $9.0 million for the year ended December 31, 2023, compared to the year ended December 31, 2022.
We capitalize interest costs on borrowings during the construction period of major construction projects as part of the cost of the constructed assets. Interest expense, net increased by $33.2 million for the year ended December 31, 2024, compared to the year ended December 31, 2023.
The decrease in fair value of the warrant liability is primarily due to the significant decrease in our closing stock price at December 31, 2023 compared to the closing stock price on the warrant issuance date.
The decrease in fair value of the warrant liability is due to the decrease in our closing stock price on December 31, 2024, compared to the closing stock price on December 31, 2023.
Factors Affecting Our Financial Condition and Results of Operations We have expended, and we expect to continue to expend, substantial resources as we: • complete construction and commissioning of new and expanded facilities; • standardize operating and manufacturing processes across our facilities; • identify and invest in future growth opportunities, including new product lines; • invest in product innovation and development; 48 • invest in sales and marketing efforts to increase brand awareness, engage customers and drive sales of our products; and • incur additional general administration expenses, including increased expenses associated with growing operations.
Factors Affecting Our Financial Condition and Results of Operations We have expended, and we expect to continue to expend, substantial resources as we: • Complete construction and commissioning of new and expanded facilities; • Standardize operating and manufacturing processes across our facilities, including increased expenses associated with growing operations; • Identify and invest in future growth opportunities, including new product lines; • Invest in product innovation and development; • Invest in sales and marketing efforts to increase brand awareness, engage customers, and drive sales of our products; and • Incur additional general administration expenses 47 Critical Accounting Estimates Management's Discussion and Analysis of Financial Condition and Results of Operations is based upon our Consolidated Financial Statements, which have been prepared in accordance with U.S.
We conduct an ongoing build-versus-buy analysis whenever we decide to build a new facility or acquire an existing facility. We also continue to explore expanding our product offerings to new varieties of fresh greens, herbs, berries, and other produce. Additionally, we evaluate commercial opportunities as part of these expansion efforts on an ongoing basis.
We conduct an ongoing build-versus-buy analysis whenever we decide to build a new facility or acquire an existing facility. We also continue to explore expanding our product offerings to new varieties of fresh greens, herbs, berries, and other produce.
We also had accrued interest of $9.8 million as of December 31, 2023. These debt agreements contain various financial and non-financial covenants and certain restrictions on our business, which include restrictions on additional indebtedness, minimum liquidity and other financial covenants, and material adverse effects, that could cause us to be at risk of default.
These debt agreements contain various financial and non-financial covenants and certain restrictions on our business, which include restrictions on additional indebtedness, minimum liquidity and other financial covenants, and material adverse effects that could cause us to be at risk of default.
Our critical accounting policies that involve significant estimates and judgments of management include the following: Goodwill We account for acquired businesses using the acquisition method of accounting which requires that the assets acquired, and liabilities assumed be recorded at the date of acquisition at their respective fair values.
Goodwill We account for acquired businesses using the acquisition method of accounting which requires that the assets acquired, and liabilities assumed be recorded at the date of acquisition at their respective fair values.
The change in fair value of the warrant is remeasured each quarter until the instrument is settled or expires with changes in fair value recorded in "Change in fair value of warrant liability" in the Consolidated Statements of Operations.
The change in fair value of the warrant is remeasured each quarter until the instrument is settled or expires with changes in fair value recorded in "Change in fair value of warrant liability" in the Consolidated Statements of Operations. Determining the appropriate fair-value model and calculating the fair value of warrants requires considerable judgment.
As of December 31, 2023, a total of $48.1 million and $269.4 million was outstanding on the Subordinated Facility and the Senior Facility, respectively. The Subordinated Facility and the Senior Facility are included in "Long-term debt" on the Consolidated Balance Sheet.
As of December 31, 2024, a total of $54.6 million and $413.4 million was outstanding on the Subordinated Facility and the Senior Facility, respectively. The Subordinated Facility and the Senior Facility are included in "Long-term debt, net of debt issuance costs" and "Short-term debt" on the Consolidated Balance Sheet.
We expect that, over time, cost of goods sold will decrease as a percentage of sales, as a result of scaling our business.
As we scale our business, we expect the cost of goods sold to decrease over time as a percentage of sales.
At December 31, 2023, our principal and estimated interest payment obligations for the Senior Facility and the Subordinated Facility are as follows (1) : (in thousands) 2024 $ 32,521 2025 67,176 2026 75,114 2027 75,114 2028 283,945 Total $ 533,870 _____________________ (1) Interest is calculated based on a 12.5% interest rate for the Subordinated Facility and a 13.86% interest rate for the Senior Facility effective as of January 1, 2024.
At December 31, 2024, our principal and estimated interest payment obligations for the Senior Facility and the Subordinated Facility are as follows (1) : (in thousands) 2025 $ 68,026 2026 90,701 2027 90,701 2028 472,248 Total $ 721,676 _____________________ (1) Interest is calculated based on a 12.5% interest rate for the Subordinated Facility and a 12.8% interest rate for the Senior Facility effective as of January 1, 2025.
Net cash used in operating activities was $48.8 million for the year ended December 31, 2022 due to a net loss of $111.1 million, partially offset by non-cash activities of $39.2 million in stock-based compensation expense, net of amounts capitalized, $5.4 million in depreciation expense, $5.0 million in amortization expense, $3.0 million in amortization of debt issuance costs, $2.6 million in loss on disposal of property and equipment, and $5.4 million net increase of cash from changes in assets and liabilities.
This was partially offset by non-cash activities of $50.3 million in paid-in-kind interest, $15.3 million in depreciation expense, $8.4 million in amortization of debt issuance costs, $3.6 million in amortization expense, $3.3 million in stock-based compensation expense, net of amounts capitalized, $1.7 million in loss on disposal of property and equipment, and a $8.8 million net increase of cash from changes in assets and liabilities.
Interest Expense, net Interest expense consists primarily of contractual interest and amortization of debt issuance costs, net of interest capitalized for construction assets, related to the loans with Cargill Financial and also interest recognized per the terms of our financing obligation related to the Montana Facility and the California Facilities.
The period-end close stock price is a key input to the Black-Scholes model we use to measure and estimate the fair value of the warrant at the end of each reporting period. 51 Interest Expense, net Interest expense consists primarily of contractual interest and amortization of debt issuance costs, net of interest capitalized for construction assets, related to the loans with Cargill Financial, and also interest recognized per the terms of our financing obligation related to the Montana Facility and the California Facilities.
Goodwill Impairment During the year ended December 31, 2023, we recognized a goodwill impairment of $38.5 million. There was no goodwill impairment recognized during the year ended December 31, 2022. See "Critical Accounting Estimates" above for more information about our goodwill impairment assessment.
Goodwill Impairment During the year ended December 31, 2023, we recognized a goodwill impairment of $38.5 million. There was no goodwill impairment recognized during the year ended December 31, 2024.
Additional cash used in investing activities related to $56.0 million of purchases of equipment and other items for the Washington, Georgia, and Texas facilities.
Net Cash Used In Investing Activities Net cash used in investing activities was $82.5 million for the year ended December 31, 2024, due primarily to purchases of equipment and other items for the Washington, Georgia, and Texas facilities.
Cost of Goods Sold Cost of goods sold consists primarily of costs related to growing produce at our greenhouse facilities, including labor costs, which include wages, salaries, benefits, and stock-based compensation, seeds, soil, nutrients and other input supplies, packaging materials, depreciation, utilities and other manufacturing overhead.
The increase was due to increased production and growth in sales from our facility in Georgia and sales from our new facilities in Texas and Washington, which began shipping and selling products in the second quarter of 2024 . 50 Cost of Goods Sold Cost of goods sold is the direct cost of growing produce for sale at our greenhouse facilities, including labor costs, which consists of wages, salaries, benefits, and stock-based compensation, seeds, soil, nutrients and other input supplies, packaging materials, depreciation, utilities, and other manufacturing overhead.
In 2022, we acquired California-based complementary greenhouse farming company Hollandia Produce Group, Inc. and its subsidiaries, which operated under the name Pete's. Through the Pete's Acquisition, we significantly increased our growing footprint to include two then-existing facilities in California and one under-construction facility in Georgia. The Georgia facility became operational in July 2022 and was further expanded in 2023.
Through the Pete's Acquisition, we significantly increased our growing footprint to include two then-existing facilities in California and one under-construction facility in Georgia. The Georgia facility initially became operational in July 2022 and was significantly expanded in 2023. In 2024, we completed construction on two new facilities in Washington and Texas, bringing our total facility count to six.
We have been able to expand distribution of our market-leading Grab & Go Salad Kits and are set to expand our baby leaf portfolio by introducing several high-velocity offerings including spinach, arugula, 50/50 blend and power greens by the third quarter of 2024.
We recently introduced new Grab & Go Salads and additions to our baby leaf portfolio with several high-velocity offerings, including Spinach, Arugula, and Basil. In addition, we introduced 50/50 blend and power greens in the third quarter of 2024.
At December 31, 2023, we had an accumulated deficit of $303.3 million and cash and cash equivalents and restricted cash of $16.9 million. As of December 31, 2023, the principal amount due under our credit facilities with Cargill Financial totaled $317.5 million, none of which is classified as current.
As of December 31, 2024, the principal amount due under our credit facilities with Cargill Financial totaled $467.9 million, of which $20.2 million is classified as current. We also had accrued interest of $15.3 million as of December 31, 2024.
Sales We derive our revenue from the sale of produce grown at our facilities. In response to realized cost inflation, we have implemented contractually allowable price increases which we anticipate to benefit from in future years. Sales increased by $8.1 million to $27.6 million for the year ended December 31, 2023, compared to the year ended December 31, 2022.
Sales We derive our revenue from the sale of produce grown at our six facilities. Sales increased by $10.6 million to $38.1 million for the year ended December 31, 2024, compared to the year ended December 31, 2023.
Derivatives On March 28, 2023, Local Bounti Operating Company LLC, the Company and certain subsidiaries entered into a Sixth Amendment to the Original Credit Agreements (the "Sixth Amendment") with Cargill Financial.
Our actual results may differ from these estimates under different assumptions or conditions. Our critical accounting policies that involve significant estimates and judgments of management include the following: Derivatives On March 28, 2023, Local Bounti Operating Company LLC, the Company and certain subsidiaries entered into a Sixth Amendment to the Original Credit Agreements (the "Sixth Amendment") with Cargill Financial.
Research and Development Research and development expenses consist primarily of costs related to research and development of our production, harvesting, and post-harvest packaging methods, techniques, and processes, as well as production surplus costs related to the development and testing of our production processes.
Research and Development Research and development expenses primarily consist of costs associated with the ongoing development, improvement, testing, alteration, and refinement of our product offerings, production lines, manufacturing processes, growing techniques, and post-harvest packaging methods.
Critical Accounting Estimates Management's Discussion and Analysis of Financial Condition and Results of Operations is based upon our Consolidated Financial Statements, which have been prepared in accordance with U.S. GAAP. Our significant accounting estimates are more fully described in Note 2, Summary of Significant Accounting Policies , to our Consolidated Financial Statements.
GAAP. Our significant accounting estimates are more fully described in Note 2, Summary of Significant Accounting Policies , to our Consolidated Financial Statements.
The increase is primarily due to an increase in the principal amount outstanding on the Senior Facility as well as a variable rate increase on the Senior Facility period over period, which increased interest expense by $8.0 million over the prior year period.
The increase is primarily due to a significant increase in the principal amount outstanding on the Senior Facility, which increased interest expense by $31.6 million over the prior year period. Also contributing to the net increase was $1.5 million of incremental interest expense for the financing obligations related to the California Facilities.
In early 2024, we will complete construction on two new facilities in Texas and Washington, bringing our total facility count to six. We now have distribution to over 13,000 retail locations across 35 U.S. sta tes , primarily through direct relationships with blue-chip retail customers, including Albertsons, Sam's Club, Kroger, Target, Walmart, Whole Foods, and AmazonFresh.
We distribute our products to approximately 13,000 retail locations across 35 U.S. states, primarily through direct relationships with blue-chip retail customers, including Albertsons, Sam's Club, Kroger, Target, Walmart, Whole Foods, Brookshire's, H-E-B, Sprouts, and AmazonFresh.
During the 12 months ended December 31, 2023 and 2022, we capitalized $14.9 million and $1.7 million of interest, respectively. Liquidity and Capital Resources We have incurred losses and generated negative cash flows from operations since our inception.
Liquidity and Capital Resources We have incurred losses and generated negative cash flows from operations since our inception. At December 31, 2024, we had an accumulated deficit of $423.2 million and cash and cash equivalents and restricted cash of $7.5 million.
The locations and degree of expansion will be announced at a future date, but construction is currently anticipated to begin late in the second quarter of 2024. The planned expansions are designed to provide additional capacity and allow for our growing product assortment to meet existing demand from our direct relationships with blue-chip retailers and distributors.
Capacity Expansion Project Update Plans remain in place to build additional capacity across our network of facilities enabled with our patented Stack & Flow Technology ® . The planned expansions are designed to provide additional capacity and allow for our growing product assortment to meet existing demand from our direct relationships with blue-chip retailers and distributors.
Our research and development efforts are focused on the development of our processes utilizing our facilities, increasing production yields, developing new leafy green SKUs and value-added products such as grab-and-go salads, and exploring new crops, including spinach, arugula, and berries.
Additionally, we also focus on the development of new leafy green product offerings, value-added products such as Grab & Go Salads, and new crops, including spinach, arugula, basil, and berries. Research and development activities are conducted at the facilities in Montana, Texas, Washington, California, and Georgia.
The overall decrease in selling, general and administrative expenses was partially offset by an increase of $2.2 million in loss on disposals charges for construction-in-progress assets, an increase of $1.7 million in professional, legal, accounting, and consulting fees, an increase of $0.9 million in amortization of intangible assets acquired as part 51 of the Pete's Acquisition, and an increase of $2.0 million in salaries, wages, and benefits due to increased headcount from Company growth and the Pete's Acquisition.
Additional decreases as compared to the prior year period were a $3.9 million decrease in salaries, benefits, and payroll-related expenses, $3.6 million decrease in legal, accounting, and professional consulting costs, and a $2.9 million decrease in loss on disposals charges primarily for construction-in-progress assets, which was partially offset by an increase of $1.0 million in insurance, and an increase of $0.9 million in transportation and delivery costs.
Cost of goods sold increased by $8.1 million for the year ended December 31, 2023, compared to the year ended December 31, 2022, due primarily to the Pete's Acquisition at the beginning of April 2022 and also due to increased production volume related to facility expansions driven by increased demand for our products and an increase in the cost of labor, utilities, and production supplies.
Cost of goods sold increased by $8.7 million for the year ended December 31, 2024, compared to the year ended December 31, 2023, due primarily to production ramp-up at our new Texas and Washington facilities and increased production at our Georgia facilities.
There were no repurchases made during the three months ended December 31, 2023. 53 Cash Flow Analysis A summary of our cash flows from operating, investing and financing activities is presented in the following table: Year Ended December 31, (in thousands) 2023 2022 Net cash used in operating activities $ (33,157) $ (48,808) Net cash used in investing activities (162,265) (172,385) Net cash provided by financing activities 187,379 145,054 Cash and cash equivalents and restricted cash at beginning of year 24,938 101,077 Cash and cash equivalents and restricted cash at end of year $ 16,895 $ 24,938 Net Cash Used In Operating Activities Net cash used in operating activities was $33.2 million for the year ended December 31, 2023, primarily due to a net loss of $124.0 million, which included a non-cash gain of $18.5 million related to change in fair value of warrant liability.
The following table summarizes future aggregate financing obligation payments by fiscal year for both the California Facilities and the Montana Facility: Financing Obligation (in thousands) 2025 $ 5,024 2026 5,158 2027 5,296 2028 5,439 2029 5,584 Thereafter 115,949 Total financing obligation payments 142,450 Cash Flow Analysis A summary of our cash flows from operating, investing, and financing activities is presented in the following table: Year Ended December 31, (in thousands) 2024 2023 Net cash used in operating activities $ (27,061) $ (33,157) Net cash used in investing activities (82,454) (162,265) Net cash provided by financing activities 100,086 187,379 Cash and cash equivalents and restricted cash at beginning of year 16,895 24,938 Cash and cash equivalents and restricted cash at end of year $ 7,466 $ 16,895 53 Net Cash Used In Operating Activities Net cash used in operating activities was $27.1 million for the year ended December 31, 2024, primarily due to a net loss of $119.9 million.
Selling, general, and administrative expenses decreased by $18.1 million for the year ended December 31, 2023, compared to the year ended December 31, 2022, primarily driven by a $22.3 million decrease in stock-based compensation and a $4.0 million decrease in transaction costs due primarily to the Pete's Acquisition in the prior year.
Selling, general, and administrative expenses decreased by $23.8 million for the year ended December 31, 2024, compared to the year ended December 31, 2023, primarily driven by a $12.9 million decrease in stock-based compensation that was a result of prior year awards that were issued at a higher fair value that fully vested and were expensed in prior periods, as compared to the fair value of awards being expensed in the current period.
We also incurred costs for research and development of our production, harvesting, and post-harvest packaging methods, techniques, and processes, as well as production surplus costs related to the development and testing of our production processes.
The increase is driven primarily by the additional development of our production, harvesting, and post-harvest packaging techniques and processes, including production surplus costs, related to the development and testing of our commercial-scale Stack & Flow Technology ® and production processes at the Washington and Texas facilities.
Our Mission and Vision Our mission is to bring our farm to your kitchen. Our vision is to deliver the freshest, locally grown produce over the fewest food miles. We believe that happy plants make happy taste buds and we are committed to reimagining the standards of freshness.
We envision a future where transformative innovation and technology combine to enable us to grow produce locally with minimal food miles, ensuring the freshest and most sustainable offerings for communities everywhere. We believe that happy plants make happy taste buds, and we are committed to reimagining the standards of freshness.
Research and development costs increased by $2.0 million for the year ended December 31, 2023, compared to the year ended December 31, 2022. The increase was due to increased investment in personnel, materials, supplies, and facility capacity usage for research and development purposes as we continue to expand our product offering and refine our growing process.
Research and development costs increased by $6.2 million for the year ended December 31, 2024, compared to the year ended December 31, 2023.
Any significant adjustments to the unobservable inputs would have a direct impact on the fair value of the warrant liability.
Any significant adjustments to the unobservable inputs would directly impact the fair value of the warrant liability. As a result of the unobservable inputs that were used to determine the expected volatility of the March 2023 Cargill Warrant, the fair value measurement of these warrants reflected a Level 3 measurement within the fair value measurement hierarchy.
Net cash provided by financing activities was $145.1 million for the year ended December 31, 2022, representing $124.6 million in proceeds from the issuance of debt and $23.3 million in proceeds from Private Placement financing (refer to Note 12, Stockholders' Equity , of the Consolidated Financial Statements for more information about the Private Placement), which was partially offset by $2.3 million payment of debt issuance costs.
Net Cash Provided By Financing Activities Net cash provided by financing activities was $100.1 million for the year ended December 31, 2024, comprised primarily of $100.1 million of net proceeds from the issuance of debt.